Key Metrics
8.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.95
5-Year SI
5-year SI
- N/A 2-year SI
- 0.92 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Cancer Research
SJR
- Q2 Cancer Research
- Q1 Molecular Biology
- Q1 Molecular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.97
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
14%
4 to 6 months
59%
7 to 9 months
23%
Above 9 months
4%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Immunotherapy
- Tumor progression
- Lung cancer
- Hepatocellular carcinoma
- Overall survival
- Neuroendocrine tumors
- Necrotic tumor
- CYP3A4
- Renal carcinoma
- Lung
- Cancer-Associated Fibroblasts
- Tumor growth
- Breast cancer
- Extracellular vesicles
- Autophagy
- Chimeric antigen receptor
- Cell cycle
- Prostate cancer
- Carcinogenesis
- Glioblastoma
Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
N6-methyladenosine modification of RIMS binding protein 2 promotes head and neck squamous cell carcinoma proliferation and radiotherapy tolerance through endoplasmic reticulum stress.
- 9 Dec 24
- Cancer gene therapy
-
Full paper
Editorial Expression of Concern: E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
- 4 Dec 24
- Cancer gene therapy
-
Full paper
Correction: A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging.
- 26 Nov 24
- Cancer gene therapy
-
Full paper
CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma.
- 25 Nov 24
- Cancer gene therapy
-
Full paper
Soft tissue sarcomas at the single-cell and spatial resolution: new markers and targets.
- 24 Nov 24
- Cancer gene therapy
-
Full paper
Establishment and characterization of the first immortalized vocal cord leukoplakia epithelial cell line.
- 23 Nov 24
- Cancer gene therapy
Scite analysis
Powered by scite_
2.7k articles received 57.5k citations see all
- 1,843 Supporting
- 55,035 Mentioning
- 157 Contrasting
Editorial notices
- 48 Retractions
- 0 Withdrawals
- 54 Corrections
- 67 Errata
- 1 Expression of Concern
FAQs
How long has Cancer Gene Therapy been actively publishing?
Cancer Gene Therapy has been in operation since 1994 till date.
What is the publishing frequency of Cancer Gene Therapy ?
Cancer Gene Therapy published with a Monthly frequency.
How many articles did Cancer Gene Therapy publish last years ?
In 2023, Cancer Gene Therapy published 140 articles.
What is the eISSN & pISSN for Cancer Gene Therapy ?
For Cancer Gene Therapy,eISSN is 1476-5500 and pISSN is0929-1903.
What is Citescore for Cancer Gene Therapy ?
Citescore for Cancer Gene Therapy is 8.4.
What is SNIP score for Cancer Gene Therapy ?
SNIP score for Cancer Gene Therapy is 0.97.
What is the SJR for Cancer Gene Therapy ?
SJR for Cancer Gene Therapy is Q2.
Who is the publisher of Cancer Gene Therapy ?
SPRINGERNATURE is the publisher of Cancer Gene Therapy.